1-19 of 19
Mazyar Shadman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and validation of predictive models of early immune effector cell-associated hematotoxicity (eIPMs)

Emily C. Liang, Jennifer J. Huang, Andrew J. Portuguese, Valentín Ortiz-Maldonado, Aya Albittar, Natalie Wuliji, Ryan Basom, Yein Jeon, Qian (Vicky) Wu, Aiko Torkelson, Delaney R. Kirchmeier, Abigail Chutnik, Barbara S. Pender, Mohamed L Sorror, Joshua A Hill, Noam E. Kopmar, Rahul Banerjee, Andrew J Cowan, Damian J Green, Ajay K. Gopal, Christina Poh, Mazyar Shadman, Alexandre V. Hirayama, Brian G. Till, Erik L. Kimble, Lorenzo Iovino, Aude G Chapuis, Folashade Otegbeye, Ryan D. Cassaday, Filippo Milano, Cameron J. Turtle, David G Maloney, Jordan Gauthier
Journal: Blood Advances
Blood Adv bloodadvances.2024014455.
https://doi.org/10.1182/bloodadvances.2024014455
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Clinical Trials & Observations
Elise A Chong, Elicia Penuel, Ellen B Napier, Rachel K Lundberg, Lihua Elizabeth Budde, Mazyar Shadman, Matthew J. Matasar, Nancy L. Bartlett, Ian W. Flinn, Francesc Bosch, Keith Fay, Andre Goy, Anita Kumar, Loretta J. Nastoupil, Michael C. Wei, Mei Wu, Shen Yin, Joseph A. Fraietta, Emeline R Chong, Stephen J. Schuster
Journal: Blood Advances
Blood Adv bloodadvances.2024013640.
https://doi.org/10.1182/bloodadvances.2024013640
Published: 2024
Includes: Supplemental data
Journal Articles

CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma

Priyanka A. Pophali, Joshua A. Fein, Kwang W. Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T. Awan, Shatha Farhan, Natalie S. Grover, Talal Hilal, Madiha Iqbal, Joseph Maakaron, Dipenkumar Modi, Elham Nasrollahi, Levanto G. Schachter, Craig Sauter, Mehdi Hamadani, Alex Herrera, Roni Shouval, Mazyar Shadman
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5290–5296.
https://doi.org/10.1182/bloodadvances.2024013863
Published: 2024
Includes: Supplemental data
Journal Articles

CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience

Clinical Trials & Observations
Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Laura Samples, Mazyar Shadman, Farrukh T. Awan, Alexandra E. Rojek, Peter A. Riedell, Madiha Iqbal, Timothy S. Fenske, Mohamed A. Kharfan-Dabaja, Sawa Ito, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3528–3531.
https://doi.org/10.1182/bloodadvances.2023012255
Published: 2024
Journal Articles

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study

Clinical Trials & Observations
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay Gopal, Stephen Smith, Ryan Lynch, Magdalena Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A. Parikh, Lindsey Roeker, John N. Allan, Richard Cheng, Chaitra Ujjani, Mazyar Shadman
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2085–2093.
https://doi.org/10.1182/bloodadvances.2023011569
Published: 2024
Journal Articles

Answering the “Doctor, can CAR-T therapy cause cancer?” question in clinic

Clinical Trials & Observations
Rahul Banerjee, Christina Poh, Alexandre V. Hirayama, Jordan Gauthier, Ryan D. Cassaday, Mazyar Shadman, Andrew J. Cowan, Brian G. Till, Damian J. Green, Hans-Peter Kiem, Ajay K. Gopal, David G. Maloney
Journal: Blood Advances
Blood Adv (2024) 8 (4): 895–898.
https://doi.org/10.1182/bloodadvances.2023012336
Published: 2024
Journal Articles

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna M. Voutsinas, Qian Wu, Cecilia C. S. Yeung, Nicolas Gazeau, Barbara S. Pender, Delaney R. Kirchmeier, Aiko Torkelson, Abigail N. Chutnik, Ryan D. Cassaday, Aude G. Chapuis, Damian J. Green, Hans-Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2024) 8 (2): 453–467.
https://doi.org/10.1182/bloodadvances.2023011287
Published: 2024
Includes: Supplemental data
Journal Articles

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Clinical Trials & Observations
Emily C. Liang, Aya Albittar, Jennifer J. Huang, Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese, Aude Chapuis, Mazyar Shadman, Brian G. Till, Ryan D. Cassaday, Filippo Milano, Hans-Peter Kiem, Stanley R. Riddell, Cameron J. Turtle, David G. Maloney, Jordan Gauthier
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6990–7005.
https://doi.org/10.1182/bloodadvances.2023011399
Published: 2023
Includes: Supplemental data
Journal Articles

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma

Clinical Trials & Observations
W. Richard Burack, Hongli Li, Diana Adlowitz, Janice M. Spence, Lisa M. Rimsza, Mazyar Shadman, Catherine M. Spier, Mark S. Kaminski, John P. Leonard, Michael L. Leblanc, Sonali M. Smith, Jonathan W. Friedberg
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5082–5090.
https://doi.org/10.1182/bloodadvances.2022009467
Published: 2023
Includes: Supplemental data
Journal Articles

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Nancy L. Bartlett, Sarit Assouline, Pratyush Giri, Stephen J. Schuster, Chan Y. Cheah, Matthew Matasar, Gareth P. Gregory, Dok Hyun Yoon, Mazyar Shadman, Keith Fay, Sung-Soo Yoon, Carlos Panizo, Ian Flinn, Anna Johnston, Francesc Bosch, Laurie H. Sehn, Michael C. Wei, Shen Yin, Iris To, Chi-Chung Li, Huang Huang, Antonia Kwan, Elicia Penuel, Lihua E. Budde
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4926–4935.
https://doi.org/10.1182/bloodadvances.2022009260
Published: 2023
Includes: Supplemental data
Journal Articles

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Chaitra Ujjani, Ted A. Gooley, Stephen E. Spurgeon, Deborah M. Stephens, Catherine Lai, Catherine M. Broome, Susan O’Brien, Haiying Zhu, Kerry J. Laing, Allison M. Winter, Georgios Pongas, Alexander L Greninger, David M. Koelle, Tanya Siddiqi, Matthew S. Davids, Kerry A. Rogers, Alexey V. Danilov, Amy Sperling, Brian Tu, Tyler Sorensen, Kelsey Launchbury, Carlissa J. Burrow, Genesis Quezada, Joshua A. Hill, Mazyar Shadman, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4728–4737.
https://doi.org/10.1182/bloodadvances.2022009164
Published: 2023
Includes: Supplemental data
Journal Articles

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Geoffrey Shouse, Andy Kaempf, Max J. Gordon, Andy Artz, David Yashar, Audrey M. Sigmund, Gordon Smilnak, Steven M. Bair, Agrima Mian, Lindsey A. Fitzgerald, Amneet Bajwa, Samantha Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M. Stephens, Manali Kamdar, Brian T. Hill, Jordan Gauthier, Reem Karmali, Loretta J. Nastoupil, Adam S. Kittai, Alexey V. Danilov
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3516–3529.
https://doi.org/10.1182/bloodadvances.2022009309
Published: 2023
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas

Clinical Trials & Observations
Ryan C. Lynch, Christina Poh, Chaitra S. Ujjani, Edus H. Warren, III, Stephen D. Smith, Mazyar Shadman, Karolyn Morris, Sydney Lee, Heather Rasmussen, Susan Ottemiller, Megan Shelby, Sarith Keo, Kaitlin Verni, David M. Kurtz, Ash A. Alizadeh, Jacob J. Chabon, Gregory J. Hogan, Andre Schulz, Ted Gooley, Jenna M. Voutsinas, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2449–2458.
https://doi.org/10.1182/bloodadvances.2022009145
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Clinical Trials & Observations
Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A. Gooley, Heather Rasmussen, David G. Coffey, Andrew J. Cowan, Stephen D. Smith, Mazyar Shadman, Edus H. Warren, Edward N. Libby, III, Alexander L. Greninger, Jonathan R. Fromm, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2023) 7 (5): 687–696.
https://doi.org/10.1182/bloodadvances.2022008628
Published: 2023
Includes: Supplemental data
Journal Articles

Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics

Clinical Trials & Observations
Mehdi Hamadani, Maud Ngoya, Anna Sureda, Qaiser Bashir, Carlos Alejandro Litovich, Hervé Finel, Yue Chen, Ariane Boumendil, Jasmine Zain, Luca Castagna, Amanda F. Cashen, Didier Blaise, Mazyar Shadman, Rocco Pastano, Farhad Khimani, Mutlu Arat, Sascha Dietrich, Norbert Schmitz, Bertram Glass, Mohamed A. Kharfan-Dabaja, Paolo Corradini, Craig S. Sauter, Silvia Montoto, Mi Kwon, Alex F. Herrera, Peter Dreger
Journal: Blood Advances
Blood Adv (2022) 6 (3): 920–930.
https://doi.org/10.1182/bloodadvances.2021005899
Published: 2022
Includes: Supplemental data
Journal Articles

Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma

Clinical Trials & Observations
Jennifer L. Crombie, Loretta J. Nastoupil, Robert Redd, Kevin Tang, Geoffrey Shouse, Alex F. Herrera, Victor A. Chow, Mazyar Shadman, Omar Castaneda Puglianini, Anna Saucier, Caron A. Jacobson, Philippe Armand, Gary Simmons
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3563–3567.
https://doi.org/10.1182/bloodadvances.2021004880
Published: 2021
Journal Articles

Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy

Clinical Trials & Observations
Victor A. Chow, Ajay K. Gopal, Jordan Gauthier, Yolanda D. Tseng, Cameron J. Turtle, David G. Maloney, Mazyar Shadman
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4869–4872.
https://doi.org/10.1182/bloodadvances.2020002292
Published: 2020
Journal Articles

Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy

Mazyar Shadman, Jordan Gauthier, Kevin A. Hay, Jenna M. Voutsinas, Filippo Milano, Ang Li, Alexandre V. Hirayama, Mohamed L. Sorror, Sindhu Cherian, Xueyan Chen, Ryan D. Cassaday, Brian G. Till, Ajay K. Gopal, Brenda M. Sandmaier, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3062–3069.
https://doi.org/10.1182/bloodadvances.2019000593
Published: 2019
Journal Articles

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Clinical Trials & Observations
Anthony R. Mato, Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, Paul M. Barr, Frederick Lansigan, Bruce D. Cheson, Arun K. Singavi, Maryam Sarraf Yazdy, Nirav N. Shah, John N. Allan, Erica B. Bhavsar, Joanna Rhodes, Kaitlin Kennard, Stephen J. Schuster, AnnaLynn M. Williams, Alan P. Skarbnik, Andre H. Goy, Julie M. Goodfriend, Colleen Dorsey, Catherine C. Coombs, Hande Tuncer, Chaitra S. Ujjani, Ryan Jacobs, Allison M. Winter, John M. Pagel, Neil Bailey, Anna Schuh, Mazyar Shadman, Andrea Sitlinger, Hanna Weissbrot, Sivraj Muralikrishnan, Andrew Zelenetz, Amy A. Kirkwood, Christopher P. Fox
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1568–1573.
https://doi.org/10.1182/bloodadvances.2019000180
Published: 2019